Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing

被引:0
|
作者
C. Eguizabal
L. Herrera
M. Inglés-Ferrándiz
J. C. Izpisua Belmonte
机构
[1] Cell Therapy,
[2] Stem Cells and Tissues Group,undefined
[3] Biocruces Bizkaia Health Research Institute,undefined
[4] Research Unit,undefined
[5] Basque Center for Blood Transfusion and Human Tissues,undefined
[6] Gene Expression Laboratory,undefined
[7] The Salk Institute for Biological Studies,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
An amendment to this paper has been published and can be accessed via the original article.
引用
收藏
相关论文
共 50 条
  • [41] Culture-free gene editing of hematopoietic stem and progenitor cells for the gene therapy of β-hemoglobinopathies
    Venkatesan, V.
    Babu, P.
    Azhagiri, M. K. K.
    Thangavel, S.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A295 - A295
  • [42] Correction of the Energetic Defects in Pyruvate Kinase Deficiency through Genome Editing in Hematopoietic Stem and Progenitor Cells
    Fananas-Baquero, Sara
    Bustamante, Oscar Quintana
    Dever, Daniel P.
    Alberquilla, Omaira
    Sanchez-Dominguez, Rebeca
    Camarena, Joab
    Turk, Rolf
    Lorenzo, Jose Luis Lopez
    Bianchi, Paola
    Behlke, Mark
    Bueren, Juan A.
    Porteus, Matt
    Segovia, Jose C.
    BLOOD, 2020, 136
  • [43] Mesenchymal stem cells at the intersection of cell and gene therapy
    Myers, Timothy J.
    Granero-Molto, Froilan
    Longobardi, Lara
    Li, Tieshi
    Yan, Yun
    Spagnoli, Anna
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (12) : 1663 - 1679
  • [44] Mesenchymal stem cells: cell and gene therapy applications
    Deans, R
    EUROPEAN CYTOKINE NETWORK, 2000, 11 (02) : 323 - 324
  • [45] Comparison of Gene Editing Strategies for Gene Correction of Wiskott-Aldrich Syndrome in Mouse Embryonic Stem Cells
    Peterson, Lisa
    Burke, J. Douglas
    Jagadeesh, G. Jaya
    Myung, Sangho
    Garrett, Lisa
    Pourebrahim, Rasoul
    Davis, Brian R.
    Candotti, Fabio
    MOLECULAR THERAPY, 2014, 22 : S216 - S217
  • [47] Correction of Type 2 Alveolar Epithelial Cell Dysfunction by Gene Editing Patient-Specific Induced Pluripotent Stem Cells
    Alysandratos, K.
    Jacob, A.
    Guttentag, S. H.
    Beers, M. F.
    Kotton, D. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [48] HAPLOIDENTICAL STEM CELL TRANSPLANTATION FOR CHILDREN WITH PRIMARY IMMUNODEFICIENCIES: EXPERIENCE IN A CENTER FROM NORTHEAST OF MEXICO
    Guadalupe Gonzalez, Maria
    Pequeno-Luevano, Myrna
    Sotomayor, Guillermo
    Baltazar, Severiano
    Staines, Tamara
    Sandoval, Adriana
    Corolla, Madia
    Venegas, Edna
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 393 - 394
  • [49] Haematopoietic stem cell gene editing for safe and effective correction of SCID-X1
    Schiroli, G.
    Ferrari, S.
    Conway, A.
    Capo, V.
    Jacob, A.
    Albano, L.
    Plati, T.
    Castiello, M. C.
    Sanvito, F.
    Bovolenta, C.
    Palchaudhuri, R.
    Scadden, D. T.
    Holmes, M. C.
    Villa, A.
    Sitia, G.
    Lombardo, A.
    Genovese, P.
    Naldini, L.
    HUMAN GENE THERAPY, 2017, 28 (12) : A51 - A51
  • [50] Efficient lentiviral transduction of Herpesvirus saimiri immortalized T cells as a model for gene therapy in primary immunodeficiencies
    Toscano, MG
    Frecha, C
    Ortega, C
    Santamaría, M
    Martín, F
    Molina, IJ
    GENE THERAPY, 2004, 11 (12) : 956 - 961